Bronstein, Gewirtz & Grossman LLC Urges Datavault AI Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Datavault AI faces a securities class action alleging it overstated the economic value of partnerships with Burke, Scilex and Nature’s Miracle, as well as trading activity on its platform. The complaint also alleges the company failed to disclose connections to a convicted felon, Withrow, creating potential reputational harm. Investors who purchased securities from September 4, 2024 through October 30, 2025 have until October 5, 2026 to seek lead-plaintiff appointment.

Analysis

This is not primarily a damages-risk event; it is a credibility and financing-risk event for DVLT. The allegations challenge the economic substance of partnership monetization and platform activity—the two inputs investors would use to underwrite revenue durability and an AI/software multiple. If subsequent filings, customer disclosures, or trading data validate even part of the claims, the likely effect is lower revenue-quality assumptions, a materially higher cost of capital, and potential dilution rather than a one-time legal reserve.

Near term, the October 5 lead-plaintiff deadline is unlikely to be a standalone fundamental catalyst, but it can sustain negative retail flow and restrict promotional/news-driven upside for several weeks. The actionable catalysts over the next 1-3 months are any amended complaint with documentary evidence, auditor commentary, delayed filings, restatement language, financing terms, or named counterparties disputing the company’s characterization of commercial arrangements. SCLX has little direct read-through absent evidence that its own contract economics or disclosures were implicated; treating it as a sympathy short would be low-conviction.

The contrarian case is that a plaintiff-lawyer announcement alone has limited informational value and often follows an already-public drawdown. DVLT can rebound sharply if it produces independently verifiable customer revenue, cash collections, and platform usage metrics; however, management assertions or non-binding partnership announcements should not close the credibility discount. The key falsifier for a bearish thesis is two consecutive reporting periods showing cash conversion consistent with claimed commercial activity, no audit/filing disruption, and no discounted capital raise.

Key Decisions for Investors

• Avoid initiating a fresh DVLT short solely on this release; wait for a failed rebound following the next corporate update or a disclosure-based catalyst. Use a tight risk limit above the post-news rebound high, since small-cap litigation names can gap on promotional liquidity despite weak fundamentals.
• For existing DVLT longs, reduce exposure or hedge over the next 1-3 months until receivables, cash collections, customer concentration, and platform activity can be independently reconciled. The downside case is a financing-driven dilution cycle, not merely legal fees.
• Set an event alert for DVLT SEC filing delays, auditor changes, going-concern language, equity-linked issuance, and amendments identifying specific revenue or activity discrepancies. Any of these converts a reputational issue into a higher-conviction short/watch-for-put opportunity.
• Do not position in SCLX on this item alone. Reassess only if SCLX confirms, disputes, or quantifies its relationship with DVLT; absent that, the company-specific legal signal does not establish a revenue or governance impairment at SCLX.